NASDAQ:AZTA • US1143401024
The current stock price of AZTA is 29.83 USD. In the past month the price decreased by -28.4%. In the past year, price decreased by -36%.
ChartMill assigns a fundamental rating of 5 / 10 to AZTA. While AZTA has a great health rating, there are worries on its profitability.
Over the last trailing twelve months AZTA reported a non-GAAP Earnings per Share(EPS) of 0.54. The EPS increased by 14.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| Debt/Equity | 0 |
14 analysts have analysed AZTA and the average price target is 40.22 USD. This implies a price increase of 34.82% is expected in the next year compared to the current price of 29.83.
For the next year, analysts expect an EPS growth of 51.12% and a revenue growth 4.59% for AZTA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.69 | 188.452B | ||
| DHR | DANAHER CORP | 24.56 | 145.876B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 140.24 | 45.865B | ||
| A | AGILENT TECHNOLOGIES INC | 20.97 | 35.035B | ||
| IQV | IQVIA HOLDINGS INC | 13.07 | 27.889B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.75 | 27.511B | ||
| WAT | WATERS CORP | 22.64 | 19.135B | ||
| ILMN | ILLUMINA INC | 23.2 | 17.803B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.63 | 17.495B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.54 | 12.062B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
AZENTA INC
200 Summit Drive, 6Th Floor
Burlington MASSACHUSETTS US
Employees: 3000
Phone: 19782622400
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
The current stock price of AZTA is 29.83 USD. The price increased by 4.16% in the last trading session.
AZTA does not pay a dividend.
AZTA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
AZTA stock is listed on the Nasdaq exchange.
The PE ratio for AZENTA INC (AZTA) is 55.24. This is based on the reported non-GAAP earnings per share of 0.54 and the current share price of 29.83 USD.
AZENTA INC (AZTA) currently has 3000 employees.